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abstract
 
CNG channels in vivo are heteromers of homologous 
 
 
 
 and 
 
 
 
 subunits that each contain a six-trans-
membrane segment domain and a COOH-terminal cytoplasmic cyclic nucleotide binding domain (BD). In heter-
ologous expression systems, heteromeric 
 
  
 
 channels activate with greater sensitivity to ligand than do homo-
meric 
 
 
 
 channels; however, ligand-gating of channels containing only 
 
 
 
 subunit BDs has never been studied
 because 
 
 
 
 subunits cannot form functional homomeric CNG channels. To characterize directly the contribution
of the 
 
 
 
 subunit BD to ligand-gating, we constructed a chimeric subunit, X-
 
 
 
, whose BD sequence was that of the
 
 
 
 subunit CNG5 from rat, but whose sequence outside the BD was derived from 
 
 
 
 subunits. For comparison, we
constructed another chimera, X-
 
 
 
, whose sequence outside the BD was identical to that of X-
 
 
 
, but whose BD se-
quence was that of the 
 
 
 
 subunit CNG2 from catﬁsh. When expressed in 
 
Xenopus
 
 oocytes, X-
 
 
 
 and X-
 
 
 
 each
formed functional homomeric channels activated by both cAMP and cGMP. This is the ﬁrst demonstration that
the 
 
 
 
 subunit BD can couple ligand binding to activation in the absence of 
 
 
 
 subunit BD residues. Notably, both
agonists activate X-
 
 
 
 more effectively than X-
 
 
 
 (higher opening efﬁcacy and lower K
 
1/2
 
). The BD is believed to
comprise two functionally distinct subdomains: (1) the roll subdomain (
 
 
 
-roll and ﬂanking A- and B-helices) and
(2) the C-helix subdomain. Opening efﬁcacy was previously believed to be controlled primarily by the C-helix, but
when we made additional chimeras by exchanging the subdomains between X-
 
 
 
 and X-
 
 
 
, we found that both sub-
domains contain signiﬁcant determinants of efﬁcacy and agonist selectivity. In particular, only channels contain-
ing the roll subdomain of the 
 
 
 
 subunit had high efﬁcacy. Thermodynamic linkage analysis shows that interaction
between the two subdomains accounts for a signiﬁcant portion of their contribution to activation energetics.
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INTRODUCTION
 
CNG channels are important for visual (Fesenko et al.,
1985; Yau, 1994) and olfactory (Nakamura and Gold,
1987) signal transduction. They conduct cations nonse-
lectively upon activation in response to direct binding
of cytoplasmic cAMP or cGMP (for review see Zagotta
and Siegelbaum, 1996). In vertebrates, six distinct ho-
mologous CNG channel genes have been identiﬁed
(called CNG1–CNG6 in the nomenclature proposed by
Biel et al., 1999). Tissue-speciﬁc combinatorial expres-
sion of paralogous subunits is likely to prove a wide-
spread strategy for customizing the dynamic range of
the CNG channel response to the tissue’s speciﬁc physi-
ological requirements. Thus, it is important to under-
stand how sequence variation among isoforms gives rise
to functional differences.
In heterologous expression systems, some isoforms
can form functional homomeric channels, whereas
other isoforms cannot; the former are termed 
 
 
 
 sub-
units, and the latter are termed 
 
 
 
 subunits (Chen et al.,
1994). All known orthologues of CNG1, 2, and 3 are 
 
 
 
subunits, and all known orthologues of CNG4, 5, and 6
are 
 
 
 
 subunits; thus, the strictly operational designa-
tion probably accurately reﬂects differences in the in
vivo function between the two groups. Channels
formed from coexpressed 
 
 
 
 and 
 
 
 
 subunits differ in
their activation and permeation properties from 
 
 
 
 sub-
unit homomers. Thus, 
 
 
 
 subunits act as modulatory
subunits, presumably coassembling with 
 
 
 
 subunits in
heteromers. It is most likely that such 
 
  
 
 heteromers
form in vivo, because functional properties of native
channels are reproduced more closely in heterologous
systems by coexpressing the relevant tissue-speciﬁc
combination of 
 
 
 
 and 
 
 
 
 paralogues than by expressing
only 
 
 
 
 homomers (Chen et al., 1993; Bradley et al.,
1994; Liman and Buck, 1994; Körschen et al., 1995;
Sautter et al., 1998; Bönigk et al., 1999; Komatsu et al.,
1999; Gerstner et al., 2000). The defect that prevents 
 
 
 
subunits from forming functional CNG channels with-
out 
 
 
 
 subunits remains unknown.
Despite their marked functional difference, both 
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and 
 
 
 
 subunits contain the conserved structural motifs
considered essential to CNG channel function, ar-
ranged with the same modular organization. All sub-
units contain a transmembrane domain homologous to
that of the voltage-gated potassium channel family (Jan
and Jan, 1992), with six putative membrane-spanning
segments S1–S6 and a reentrant “P-loop” between S5
and S6. The P-loop controls the conductance and phar-
macology of the aqueous pore (Goulding et al., 1993;
Kramer et al., 1994; Root and MacKinnon, 1994) as it
does in potassium channels (MacKinnon, 1995). Like
the voltage-gated potassium channels, CNG channels
formed from 
 
 
 
 subunits are tetrameric (Gordon and
Zagotta, 1995a; Liu et al., 1996), and 
 
  
 
 heteromers
are thought to be also tetrameric with two 
 
 
 
 and two 
 
 
 
subunits (Shapiro and Zagotta, 1998; Shammat and
Gordon, 1999; He et al., 2000). At the cytoplasmic
COOH-terminal end of S6, all CNG channel subunits
contain a highly conserved “C-linker” region of 
 
 
 
80
residues, followed by a cyclic nucleotide binding do-
main (BD)* homologous to those of cAMP-dependent
protein kinases and the catabolite activator protein
(CAP) of 
 
Escherichia coli
 
 (Kaupp et al., 1989; Shabb and
Corbin, 1992). The BDs of both 
 
 
 
 and 
 
 
 
 subunits in 
 
  
 
heteromers can be labeled by photoreactive agonists
(Brown et al., 1995), and the BD is a natural focus for
studies of CNG channel activation properties. Unfortu-
nately, since the cyclic nucleotide activation properties
of 
 
 
 
 subunits cannot be studied in the absence of 
 
 
 
 sub-
units, it has not been possible to make a direct compar-
ison of the functional consequences of sequence differ-
ences between the 
 
 
 
 and 
 
 
 
 subunit BDs.
Structure–function studies of the BD in 
 
 
 
 homomers,
guided by homology modeling, suggest that the BD it-
self has a modular organization, with two structural sub-
domains that are also functionally distinct. The homol-
ogy models (Kumar and Weber, 1992; Varnum et al.,
1995; Scott et al., 1996) were based on the known 3-D
structures of the cAMP-liganded BDs in CAP (Weber
and Steitz, 1987) and PKA (Su et al., 1995). In these
structures, the BD contains a roll subdomain and a
C-helix subdomain separated by a proline residue: the
roll subdomain consists of a “
 
 
 
-roll” of four pairs of anti-
parallel 
 
 
 
-strands (
 
 
 
1 through 
 
 
 
8) ﬂanked by two short
 
 
 
-helices (A- and B-helix), and the C-helix subdomain
consists of a single, long 
 
 
 
-helix. The cyclic nucleotide
molecule sits between these two subdomains, with the
cyclic phosphate moiety contacting the 
 
 
 
-roll and the
purine moiety contacting the C-helix. The C-helix, and
in particular residue 604 (see 
 
materials and methods
 
for numbering convention), serves as the major deter-
minant of cGMP selectivity in certain 
 
 
 
 subunit BDs
(Goulding et al., 1994; Varnum et al., 1995); similarly,
mutations in the 
 
 
 
 subunit BD at position 604 inﬂuence
the selectivity of 
 
  
 
 heteromers (Pagès et al., 2000; Sha-
piro and Zagotta, 2000; He and Karpen, 2001). A cur-
rent model for C-helix function is that the purine ring’s
interaction with the C-helix is stronger when the chan-
nel is open than when the channel is closed, and as a
consequence, this interaction contributes “activation
coupling energy” to preferential stabilization of the
open state (increasing open probability). In contrast,
the cyclic phosphate interaction with the roll subdo-
main is state-independent (Tibbs et al., 1998) and so
contributes binding energy to strengthen the afﬁnity of
the BD for ligand without contributing coupling energy.
In this light, the previous observations that the 
 
 
 
 sub-
unit BD contributes to 
 
  
 
 heteromer activation leave
open the question of how much activation coupling en-
ergy and/or binding energy can be derived from the 
 
 
 
subunit BD itself. Interactions between BDs of neigh-
boring subunits have been proposed to contribute to
activation coupling energy in 
 
 
 
 homomers (Liu et al.,
1998; Paoletti et al., 1999), and CAP forms a ho-
modimer in which interaction between subunits is
essential for activation (Cheng et al., 1995); thus, an
attractive hypothesis is that the 
 
 
 
 subunit BD must in-
teract with the BD of a neighboring 
 
 
 
 subunit to con-
tribute signiﬁcant coupling energy to channel activa-
tion. This would predict that a channel containing only
 
 
 
 subunit BDs and no 
 
 
 
 subunit BDs would be incom-
petent or inefﬁcient in coupling ligand binding to
opening, or might even fail to bind agonist at all. In
this report, we provide the ﬁrst direct evidence that the
 
 
 
 subunit BD can bind ligand and efﬁciently couple
binding to channel opening, without assistance from 
 
 
 
subunit BD residues. Our approach was to construct a
chimeric CNG channel subunit composed of 
 
 
 
 subunit
sequence, in which the 
 
 
 
 subunit BD sequence has
been replaced with the BD sequence from a 
 
 
 
 subunit
—namely rat CNG5 (rCNG5), the ﬁrst olfactory 
 
 
 
 sub-
unit to be cloned (Bradley et al., 1994; Liman and
Buck, 1994). This chimera (called X-
 
 
 
) forms func-
tional homomeric channels that are efﬁciently acti-
vated by cyclic nucleotide. Our result deﬁnitively rules
out the possibility of a BD defect, and allows us to con-
clude that the 
 
 
 
 subunit rCNG5 is deﬁcient only in se-
quence regions outside the BD. We compared X-
 
 
 
 with
other similar chimeras that contain 
 
 
 
 subunit BDs but
that are identical to X-
 
 
 
 in all sequence outside the BD.
This provided the ﬁrst direct functional comparison of
BDs from 
 
 
 
 and 
 
 
 
 subunits as they operate in homo-
meric channels, and had several unanticipated ﬁnd-
ings. The rCNG5 BD in X-
 
 
 
 turns out to be more effec-
tive in ligand-gating than some 
 
 
 
 subunit BDs, such as
that from the olfactory 
 
 
 
 subunit CNG2 from catﬁsh
 
*
 
Abbreviations used in this paper:
 
 bCNG1, bovine CNG1; BD, binding
domain; CAP, catabolite activator protein; fCNG2, catfish CNG2;
rCNG2 and 5, rat CNG2 and rat CNG5, respectively. 
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(fCNG2; Goulding et al., 1992). We demonstrate that
the differences in activation properties between the
chimeras containing rCNG5 and fCNG2 BDs are deter-
mined by both the C-helix and roll subdomain se-
quences, and that the roll subdomain from the fCNG2
BD imparts an unusual new form of agonist selectivity,
namely agonist-selective desensitization. Finally, we
demonstrate that the roll and C-helix subdomains in-
teract strongly with each other in determining prefer-
ential open state stabilization.
 
MATERIALS AND METHODS
 
Molecular Subcloning
 
All CNG channel subunits and chimeras were subcloned into the
oocyte expression vector pGEM-HE (Liman et al., 1992). Chime-
ras were constructed from the 
 
 
 
 subunit CNG1 from bovine rod
photoreceptors (bCNG1; Kaupp et al., 1989), 
 
 
 
 subunit CNG2
from catﬁsh olfactory neurons (fCNG2; Goulding et al., 1992),
and 
 
 
 
 subunit CNG5 from rat olfactory neurons (rCNG5; Bradley
et al., 1994; Liman and Buck, 1994). (Note: CNG5 also has been
called OCNC2, OCNC
 
 
 
, olfactory 
 
 
 
, or CNC
 
 
 
4.) The chimeric 
 
 
 
subunit ROON-S2 was previously described (Tibbs et al., 1997)
and consists of bCNG1 in which bCNG1 N91-S240 (i.e., “N-S2” re-
gion; Goulding et al., 1994) is replaced by fCNG2 E89-R215, and
bCNG1 A344-A378 (i.e., P-loop) is replaced by fCNG2 S314-F348.
The BD sequences are deﬁned as bCNG1 L485-A614, and the ho-
mologous sequences are deﬁned as fCNG2 L455-G584 and
rCNG5 L356-A485. These three 130-residue BD sequences can be
aligned with no gaps. Since most extant literature deals with
bCNG1, for the sake of uniformity in the text an individual BD
residue is referred to by its corresponding position number in
bCNG1 regardless of the residue’s identity or its position number
in a particular subunit chimera. The C-helix sequence is deﬁned
as bCNG1 D588-A614, and corresponding sequences in fCNG2
and rCNG5. X-
 
 
 
 is ROON-S2 in which the bCNG1 BD is replaced
by the rCNG5 BD. X-
 
 
 
 is ROON-S2 in which the bCNG1 BD is re-
placed by the fCNG2 BD. The subscripted symbols 
 
 
 
R
 
 and 
 
 
 
C de-
note the   subunit fCNG2 roll (R) and C-helix (C) subdomains,
respectively, and the symbols  R and  C denote   subunit rCNG5
roll and C-helix subdomains, respectively. Hence, X- R/ C has a
BD that contains the roll subdomain (R) from the   subunit
fCNG2, and the C-helix (C) from the   subunit rCNG5; speciﬁ-
cally, it is X-  in which the fCNG2 C-helix is replaced by the
rCNG5 C-helix. Similarly, X- R/ C is X-  in which the rCNG5 ( 
subunit) C-helix is replaced by the fCNG2 (  subunit) C-helix.
Chimeras were constructed using PCR techniques as described
previously (Goulding et al., 1993; Paoletti et al., 1999); all four
X-chimeras were dideoxy sequenced in their entirety.
Patch-clamp Recording of Macroscopic Currents
Xenopus oocytes were prepared and injected with 0.25–25 ng
RNA transcribed from linearized cDNA as previously described
(Paoletti et al., 1999). Inside-out patches were obtained from oo-
cytes 1–5 d after injection, using electrodes of resistance 1–5 M .
Divalent-free solution (Liu et al., 1998) was identical in both pi-
pette and bath, and contained the following (in mM): 67 KCl, 30
NaCl, 10 HEPES, 10 EGTA, 1 EDTA, pH 7.2 with KOH. For Ni2 
potentiation experiments, the pipette solution was unchanged,
whereas the bath (intracellular) solution contained 89 mM KCl,
with 5 or 10  M NiCl2 (Sigma-Aldrich) included and EGTA and
EDTA omitted. Na-cGMP or Na-cAMP (Sigma-Aldrich) were in-
cluded as needed in the bath solution by iso-osmolar replace-
ment of NaCl. Patches were washed continuously with bath solu-
tion by a gravity perfusion system. Data was acquired with an Axo-
patch 200A ampliﬁer (Axon Instruments), recorded via a VR10B
digital data recorder (Instrutech) to VHS tape in a VCR (model
VC-A206; Sharp), ﬁltered at 4 kHz (eight-pole Bessel, No. 900;
Frequency Devices) and digitized at 1 kHz with either a DigiData
1200 interface and pClamp 6.0, or a Digidata 1320A interface
and pClamp 8.0 (Axon Instruments, Inc.).
Macroscopic current in the presence of agonist was measured
after steady-state current level was reached at a holding voltage of
 80 mV; currents from two to four repetitions of a voltage step
protocol ( 100 to  100 mV in 40-mV steps) were averaged, and
corrected by subtraction of capacitance transients and leak cur-
rents obtained by running the same protocol in agonist-free solu-
tion. Dose–response curves were measured from currents at
 100 mV; rectiﬁcation was calculated from the ratio of currents
at  60 and  60 mV. To verify time-stationarity of the dose–
response curve, measurements at selected saturating and subsat-
urating agonist concentrations were repeated before and after
dose–response data collection. The criterion for stationarity was
that the duplicate measurements deviate by  15% from each
other. Spontaneous changes in maximal current amplitudes and
in K1/2 were observed (”runup” and/or “rundown”) and the time
required to reach stationarity was variable, often  10 min after
patch excision. This is signiﬁcantly longer than the  5-min times
reported previously for spontaneous dephosphorylation at Y498
of bCNG1 (Molokanova et al., 1999), and may be due to the pres-
ence of an additional unknown phosphorylation site.
Potentiation of channel activation by intracellular Ni2  in satu-
rating cAMP concentration was measured as follows. Macroscopic
currents in 30 mM cAMP plus 5–10  M Ni2  (Imax,cAMP Ni) were
measured at  80 mV. These measurements were bracketed by
measurements of currents in 30 mM cAMP without Ni2 , which
were averaged to give Imax,cAMP. The Ni2  concentration was satu-
rating since 5 and 10  M Ni2  produced identical potentiation.
Fitting of Dose–Response Curves
For chimeras X-  and X- R/ C, complete macroscopic current
dose–response curves ( 4 concentrations distributed from satu-
rating level to below K1/2) were collected from individual
patches. For each curve, response current I at a given agonist
concentration, [A], was ﬁtted with the Hill equation, I   Imax/(1  
(K1/2/[A])h), where K1/2 is the concentration of agonist A elicit-
ing half-maximal activation, h is the Hill coefﬁcient, and Imax is
the maximal current amplitude. Data were weighted by 1/SD
during ﬁtting (SigmaPlot). The K1/2 selectivity ratio (K1/2,cGMP/
K1/2,cAMP) was evaluated for each patch; a value  1 for this ratio
corresponds to cAMP selectivity.
For the low efﬁcacy chimeras, X-  and X- R/ C, stationarity
was often not reached until very long times (20–40 min) after
patch excision, and complete macroscopic dose–response curves
could not always be collected before degradation of patch qual-
ity. Therefore, complete and partial datasets for each chimera
(all sets checked for stationarity) were composited as follows. For
each patch, currents were normalized by dividing by the current
measured in the same patch in 3 mM cGMP. Normalized data for
all patches of a given chimera were then pooled and averaged to
give a mean relative current, Irel, for each agonist concentration
[A]. This composite dataset was then ﬁtted (weighted by 1/SD)
with the Hill equation, Irel   Imax,rel/(1   (K1/2/[A])h), where
K1/2 and h are the usual Hill parameters and Imax,rel is the maxi-
mal relative current amplitude. The K1/2 selectivity ratio was cal-
culated as K1/2,cGMP/K1/2,cAMP. To plot data in terms of open prob-
ability for illustrative purposes (see Figs. 5 and 6), the composite
dataset and ﬁtted Hill equation for both cAMP and cGMP activa-
tion were multiplied by the factor Pmax,cAMP/Imax,rel,cAMP, where526 Efficient Coupling by a CNG Channel   Subunit Binding Domain
Figure 1. A chimeric CNG channel subunit containing the BD from a modulatory ( ) subunit forms a functional homomeric CNG
channel. (A) Schematic of CNG channel subunit sequence showing six transmembrane segments (vertical rectangles) and a cytoplasmic
COOH-terminal binding domain with two parts: the roll subdomain (a  -roll ﬂanked by A- and B-helices, shown as an omega-shaped loop)
followed by the C-helix (horizontal rectangle). Chimera X-  consists of   subunit bCNG1 sequence (thin black lines) with N-S2 region and
P-loop replaced by those of the   subunit fCNG2 (thick gray), and the BD replaced by that of the   subunit rCNG5 (striped). (B, top
traces) Macroscopic currents from X-  homomeric channels in an inside-out patch, elicited in response to perfused cyclic nucleotide
(open bars). Washout of agonist takes several seconds (dotted outline of bars). Holding voltage is  80 mV. Gap in each current trace dur-
ing perfusion represents an arbitrary interval during which the voltage-step protocol was performed. (bottom traces) Currents elicited in527 Young et al. 
Pmax,cAMP is the mean efﬁcacy in cAMP determined from single-
channel recordings (see next section).
Single-channel Recording and Analysis
Solutions and instrumentation for recording single-channel cur-
rents in inside-out patches were identical to those used in macro-
scopic current experiments; pipettes were coated with Sylgard
184 (Corning). Currents were recorded from either 10–150-s
stretches of data at  80 mV or 800-ms pulses at  80 mV, and
were digitized at 20 kHz. As reported for previous observations of
intact fCNG2 (Goulding et al., 1992), we sometimes observed
slow (1–5 s timescale) slight ﬂuctuations in open probability or,
infrequently, periods of complete inactivity lasting 0.5–5 s; how-
ever, we did not observe sudden switching between long-lived
(5–10 s) modes with very low Popen and very high Popen.
Continuous single-channel records were visually inspected and
manually baseline-corrected (Clampﬁt 8.0). All-points amplitude
histograms were compiled for each record and each was ﬁtted
(custom routine in LabScript; Origin 5.0) with a sum of Gaussian
peaks representing a single closed state and either a single open
state (at  80 mV) or multiple open states (at  80 mV). In the ﬁt,
the Gaussian means, amplitudes, and SDs were free parameters;
amplitudes were constrained to be positive and SDs constrained
to the range 0.05–1 pA. Goodness of ﬁt was judged by satisfaction
of three criteria: (1) visual inspection, (2)  2 decreased by a fac-
tor of  10 7 with successive Levenburg-Marquardt iterations,
and (3) total ﬁt residuals were less than the area of the least-pop-
ulated Gaussian component. To determine open state conduc-
tances, the ﬁtted open state Gaussian means were corrected by
subtraction of the ﬁtted closed state Gaussian mean.
The closed probability Pclosed was calculated as the area of the
closed state Gaussian divided by the area of the summed Gauss-
ians. For some records with Pclosed   0.01, the closed state Gaussian
mean was ﬁxed at zero to ensure a good ﬁt. For one X-  record-
ing, the closed state Gaussian area was less than the total ﬁt residu-
als when other goodness of ﬁt criteria were satisﬁed, so an upper
limit for Pclosed was calculated by dividing the total ﬁt residuals by
the area of the summed Gaussians (0.0002). For records with large
Pclosed, where the histogram was dominated by a single closed state
peak, only the histogram data on the side of the peak away from
the open state was ﬁtted to a single Gaussian; Pclosed was calculated
as the area of the Gaussian divided by the total histogram area. Fi-
nally, open probability was calculated as Popen   1   Pclosed.
Pmax was determined as Popen at  80 mV in concentrations of
agonist as follows, with range and mean   SD of data record
lengths given in parentheses: for X- , 3 mM cAMP (14–59 s,
mean 39   18 s) or 3 mM cGMP (30–146 s, mean 62   48 s); for
X- , 10–30 mM cAMP (15–56 s, mean 29   13) or 3 mM cGMP
(17–55 s, mean 30   11 s); for X- R/ C, 30 mM cAMP (23–111 s,
mean 53   28 s); and for X- R/ C, 30 mM cAMP (26–66 s, mean
54   16 s) or 30 mM cGMP (32–98 s, mean 60   26 s). Where ap-
plications of the noted agonist concentration occurred more
than once over the course of a patch experiment, only the re-
cording from the later application was included.
Unless otherwise noted, all experimental uncertainties reported
are  SD, with n being the number of patches, and signiﬁcance was
assessed by t test (population comparisons by unpaired t test).
RESULTS
Construction of a Chimeric CNG Channel Subunit 
Containing the BD of a   Subunit
We sought to examine the unknown functionality of the
BD of the   subunit CNG5; to date, the only functionally
characterized CNG5 subunit is that from rat (rCNG5).
This subunit was the ﬁrst modulatory subunit found in
CNG channels of olfactory epithelium (Bradley et al.,
1994; Liman and Buck, 1994); it also exists in vomerona-
sal neurons (Berghard et al., 1996) and hippocampus
(Bradley et al., 1997). Our strategy was to incorporate
the rCNG5 BD sequence into a chimeric channel sub-
unit that contained  -subunit sequence outside the BD.
We also anticipated comparing this chimera with other
similar chimeras, incorporating the BDs from a variety
of channels into the same non-BD sequence; differences
in function among all of these chimeras must directly re-
ﬂect differences in their BD sequences. This projected
comparative study would require both single channel
and macroscopic current measurements on all chime-
ras, but we anticipated that some BDs might function
very poorly in ligand-gating and thereby produce chime-
ras with low activity. Thus, we chose the non-BD se-
quence of our chimeras to impart a large single-channel
conductance and a channel opening transition that was
intrinsically energetically favorable.
The non-BD sequence in our chimeras is that of a pre-
viously characterized chimeric   subunit, ROON-S2
(Tibbs et al., 1997, 1998). ROON-S2 consists of the
full-length sequence of the   subunit of bovine
rods (bCNG1; Kaupp et al., 1989) in which selected
sequences have been replaced by corresponding se-
quences from the   subunit of catﬁsh olfactory neurons
(fCNG2; Goulding et al., 1992). Replacement of the
P-loop imparts a larger single-channel conductance, but
does not affect channel activation (Goulding et al.,
1993). Replacement of the “N-S2” region (comprising
the portion of the transmembrane domain NH2-termi-
nal to S3 together with the immediately adjacent portion
of the cytoplasmic NH2 terminus) imparts a more favor-
able energy of opening in the absence of agonists and a
parallel enhancement of channel activation for any ago-
nist (Goulding et al., 1994). In ROON-S2 as well as in
other previously characterized chimeras (Goulding et
al., 1994), the replacement of bCNG1 N-S2 with fCNG2
N-S2 leaves unchanged the agonist selectivity derived
from the BD, which suggests strongly that the canonical
steady-state concentrations of cyclic nucleotide (as indicated in top traces) were measured during voltage pulses from 0 mV to potentials
between  100 and  100 mV in intervals of 40 mV. Traces are averages of duplicate trials and are leak subtracted. (C) Relative currents
from the patch shown in B at  100 mV in response to cAMP (closed circles) or cGMP (open circles). Lines show ﬁts of the Hill equation
with parameters (  SE) as follows: for cAMP (solid line), K1/2   40.3   2.8  M, h   2.08   0.16; for cGMP (dashed line), K1/2   57.1  
4.0  M, h   1.94   0.13; Imax,cAMP/Imax,cGMP   0.996   0.021. (D) Outward rectiﬁcation in the same experiments shown in C, measured by
the ratio of currents at  60 and  60 mV for different agonist concentrations.528 Efficient Coupling by a CNG Channel   Subunit Binding Domain
ligand-gating mechanism is also unchanged. ROON-S2
can be expressed as functional homomers in oocytes ei-
ther at the single-channel level or at very high levels pro-
ducing large macroscopic currents. Thus the non-BD se-
quence of ROON-S2 provides a suitable platform for
testing function of a variety of BD sequences. Our new
chimera, X- , is identical to ROON-S2 from the NH2 ter-
minus to the end of the C-linker (denoted by the X- pre-
ﬁx) but contains the BD of rCNG5 (see Fig. 1 A).
When RNA for X-  alone is injected into oocytes, large
currents are elicited in inside-out patches in response to
cyclic nucleotide (Fig. 1 B). Both cAMP and cGMP are
full agonists for activating X- , and the dose–response
curves (Fig. 1 C) exhibit steep Hill coefﬁcients, indicat-
ing that multiple agonist molecules contribute to chan-
nel activation. This result stands in marked contrast with
the failure of intact rCNG5 to express functional homo-
meric channels, and shows that the BD of rCNG5 is com-
petent to bind cyclic nucleotide and to engage the cou-
pling machinery that promotes channel opening.
We next characterized more closely the gating prop-
erties of X- . Maximal currents (Imax) elicited by satu-
rating concentrations of cAMP and cGMP are similar.
However, at low agonist concentrations, the channel is
clearly more sensitive to cAMP than to cGMP, i.e., the
K1/2 for cAMP is lower than that for cGMP (Fig. 1 C).
This is consistent with the observation that heteromers
of rCNG5 with rat CNG2 (rCNG2) exhibit enhanced
cAMP activation compared with homomers of rCNG2
(Bradley et al., 1994; Liman and Buck, 1994). An em-
pirical measure of the agonist selectivity of X-  is the ra-
tio K1/2,cGMP/K1/2,cAMP. Since absolute K1/2 values of
CNG channels typically vary from patch to patch (Ruiz
et al., 1999), it is more reliable to evaluate the K1/2 ratio
for each patch individually than to take one ratio of the
mean values of K1/2,cGMP and K1/2,cAMP. In every macro-
scopic current patch of X-  channels, the K1/2 ratio was
 1 (indicating cAMP selectivity); the mean of the indi-
vidual ratios was 1.45   0.13 (n   9), which indicates
the cAMP selectivity is statistically signiﬁcant (P   
0.0001). It has also been reported that coexpression of
rCNG5 with rCNG2 leads to a marked increase in out-
ward rectiﬁcation compared with rCNG2 homomers,
and to a slow (seconds timescale) desensitization in re-
sponse to application of millimolar concentrations of
agonist (Bradley et al., 1994; Liman and Buck, 1994).
In contrast, over a range of agonist concentrations, X- 
currents exhibit only weak outward rectiﬁcation (Fig. 1
Figure 2. Single-channel recordings of homomeric X-  channels show high efﬁcacy of opening with either cAMP or cGMP. (A1–A4)
Typical 750-ms excerpts of recordings from one single-channel patch at  80 and  80 mV, with steady-state concentration of agonist as in-
dicated; closed and open state current levels are marked by c and o, respectively.529 Young et al. 
D) typical of   subunits containing the NH2-terminal
region of CNG2 (Goulding et al., 1992; Möttig et al.,
2000), and exhibit no slow desensitization (up to 30 mM
agonist; unpublished data). This shows that rCNG5 se-
quence outside the BD is not only sufﬁcient for marked
rectiﬁcation and desensitization (Shapiro and Zagotta,
2000), but is also absolutely necessary.
Single Channels of X-  Display High Efﬁcacy and
Normal Conductance
Single-channel recordings of X-  show that at 3 mM
(saturating) cAMP or cGMP, the efﬁcacy of opening
(or maximum open probability, Pmax) is very high (Fig.
2, A3 and A4). Channel closings are rare and short-
lived. For cAMP, Pmax   0.980   0.025 (n   6), and for
cGMP, Pmax   0.947   0.068 (n   5). Open probability
has a strongly nonlinear relationship with the thermo-
dynamic parameter (free energy) associated with the
closed-open conformational change; when Popen is close
to 1, a small variation in Popen represents a signiﬁcant
energetic difference in activation. To measure efﬁcacy
in thermodynamic terms, we used Pmax values to calcu-
late the free energy of opening with saturating agonist
concentrations ( Gsat), according to a simple model
with a single open and closed state
where AnC is the fraction of channels in the closed state
with all n ligand binding sites occupied and AnO is the
fraction of fully liganded channels in the open state.
According to this simple Scheme I,  Gsat      RT
ln([AnO]/[AnC])    RT ln(Pmax/(1   Pmax)).
CNG channels composed of wild-type subunits are
known to exhibit variation in activation properties at
the single-channel level (Ruiz et al., 1999). Single X- 
channels also had efﬁcacies that varied from patch to
patch over a  15-kJ/mol range, with mean values of
 Gsat,cAMP    12.8   5.6 kJ/mol (n   6) and  Gsat,cGMP
   9.5   4.8 kJ/mol (n   5). To evaluate agonist se-
lectivity in the presence of patch-to-patch variation, we
compared  Gsat for cAMP and cGMP for each individ-
ual patch. The “efﬁcacy selectivity” value,  Gsel   
  Gsat,cAMP    Gsat,cGMP, was negative in every patch, with
a mean ( 4.2   1.7 kJ/mol, n   5), which is signiﬁ-
cantly less than zero (P   0.02). The negative value in-
dicates that X-  is selective for cAMP over cGMP in
terms of efﬁcacy, just as for the K1/2 selectivity ratio.
Single-channel currents of X-  exhibit three open
state conductances at  80 mV, but only one open state
conductance at  80 mV (seen in all-points histograms,
Fig. 3). These conductances match those previously de-
(SCHEME I)
scribed and attributed to external proton block in
fCNG2, and in chimeric channels containing the
fCNG2 P-loop, including ROON-S2 (Goulding et al.,
1992; Root and MacKinnon, 1994; Liu et al., 1996;
Tibbs et al., 1998). The largest of the three conduc-
tances at  80 mV is  75 pS and corresponds to an un-
blocked state (O0). The two subconductances are at-
tributed to block by one proton (O ,  50 pS) or two
protons (O  ,  25 pS; Root and MacKinnon, 1994),
and account for  95% of the channel open time, giv-
ing a mean conductance of  42 pS at  80 mV. Relief
of proton block at positive voltages (giving a mean con-
ductance  56 pS at  80 mV) accounts for the outward
rectiﬁcation seen in macroscopic currents at saturating
agonist concentrations when Popen is  1 (Fig. 1 C).
Preservation of the conductance properties of ROON-
S2 in the new chimera X-  indicates that the substitu-
tion of the BD did not dramatically affect the structure
of the open aqueous pore. This makes it unlikely that
the activity of X-  in the oocytes depends on coassem-
bly with an endogenous subunit, and also makes it un-
likely that the transmembrane moiety of an X-  ho-
momer has a structure signiﬁcantly different than that
of homomers of ROON-S2 or intact fCNG2. In sum-
mary, X-  shows all the essential functional properties
of an intact   subunit: it assembles into homomeric
channels that are activated by cyclic nucleotide in a se-
lective fashion, and which exhibit conductance proper-
ties that match those predicted from the transmem-
brane domain sequence.
The BD of the   Subunit Produces More Efﬁcient Activation 
than the BD from an   Subunit
The high Pmax and steep Hill coefﬁcient of X-  indicate
highly effective activation by ligands. This clearly rules
out one plausible explanation for failure of the   sub-
unit to form functional homomers, namely that the BD
is incapable of strong coupling of ligand binding to
channel opening. We were now in a position to make a
comparative study asking, how does the performance
of the rCNG5 BD (in the context of X- ) compare with
that of BDs from closely related   subunit homologues?
The BD of bCNG1 is present in the previously charac-
terized ROON-S2; for further comparison we con-
structed a new chimera, X- , identical to X-  and to
ROON-S2 up to the end of the C-linker, but containing
the BD of fCNG2, another   subunit.
X-  is activated to similar extents by both cAMP and
cGMP, like X- . However, X-  exhibits an unusual de-
sensitization at high concentrations of cGMP (to be dis-
cussed below) so we ﬁrst focus on cAMP activation. X- 
preserves the very weak rectiﬁcation (Fig. 4 A, voltage
step traces) and single-channel conductance proﬁle at
 80 and  80 mV (Fig. 4 B; unpublished all-points his-
tograms) that are characteristic of the X-based chime-530 Efficient Coupling by a CNG Channel   Subunit Binding Domain
Figure 3. X-  has normal single-channel conductance. (A1–A4) All-points current amplitude histograms compiled from the excerpts in
Fig. 2 (A1–A4 respectively). Insets expand the feet of histograms in A1 (30  M cAMP, very low Popen) and A3 (3 mM cAMP, very high Popen).
With the exception of the histogram in A1 at  80 mV (materials and methods), the complete histograms (connected dots) were ﬁtted
with a sum (solid line) of Gaussian peaks (dashed lines). Arrows mark current means for multiple open states at  80 mV: O0 (unproto-
nated), and O  and O   (single and doubly protonated, respectively). Popen values from the excerpts are as follows: in 30  M cAMP, 0.0745
at  80 mV and 0.015 at  80 mV; in 300  M cAMP, 0.943 at  80 mV and 0.9299 at  80 mV; in 3 mM cAMP, 0.9929 at  80 mV and 0.9905
at  80 mV; and in 3 mM cGMP, 0.9523 at  80 mV and 0.9671 at  80 mV.
ras, conﬁrming that these properties are determined by
the invariant sequence outside the BD. However, sin-
gle-channel recordings of X-  at 30 mM cAMP (Fig. 4
B4) show lower opening efﬁcacy (mean Pmax,cAMP of
0.49   0.30, n   9) than seen for X-  (Pmax,cAMP  
0.980   0.025, n   6). There is a large variation in Pmax
of X-  from patch to patch, which reﬂects the fact that
when the open and closed states have similar stability
(Popen near 0.5), small differences in the energetics of
the opening reaction are manifest as numerically large
changes in Popen. Despite this variation, the range of
Pmax values for X-  (0.1150–0.9549) is clearly distinct
from the range observed for X-  (range 0.9342–
0.9998). Furthermore, when the Pmax values are ex-
pressed as free energies (mean  Gsat,cAMP for X-  is
 0.1   4.1 kJ/mol; n   9) the patch-to-patch variation
(range of  13 kJ/mol) turns out to be similar in mag-
nitude to that found for X- , and is thus probably531 Young et al. 
Figure 4. Chimeric CNG channel subunit X-  containing BD from
the   subunit fCNG2 is less efﬁciently activated by cAMP than is X- .
(A) Schematic shows sequence of X-  is identical to that of X-  ex-
cept that the BD sequence is that of fCNG2. (top traces) Macroscopic
current traces from homomeric X-  channels elicited by the indi-
cated concentrations of cAMP. (bottom traces) Currents during volt-
age steps at indicated steady-state cAMP concentrations (tested as in
Fig. 1). (B1–B4) Excerpts of single X-  channel recordings at indi-
cated potentials and steady-state cAMP concentrations (collected as
in Fig. 2). Popen values from the excerpt in B4 (30 mM cAMP) are
0.778 at  80 mV and 0.646 at  80 mV. (C) Dose–response data
(closed circles) for X-  activation by cAMP at  100 mV, from the
patch shown in A. Solid line shows Hill equation ﬁt with K1/2   717  
47  M, h   1.241   0.051, and the graph is normalized with Pmax,cAMP
at cAMP set to be 0.49, the mean from single-channel measurements.
For comparison, the dashed line shows cAMP dose–response curve
for X- , taken from Fig. 1 C and normalized using the Pmax,cAMP of
0.98 derived from single-channel measurements.532 Efficient Coupling by a CNG Channel   Subunit Binding Domain
Figure 5. Chimera X-  is less efﬁciently activated by cGMP than is X- , and exhibits desensitization at high cGMP concentrations. (A, top
traces) Macroscopic current traces from homomeric X-  channels (different patch than that shown in Fig. 4 A), elicited by indicated con-
centrations of agonist. Channels desensitize in 30 mM cGMP and recover to the activation level of 3 mM cGMP during the slow washout of
agonist (dotted portion of open bars). (bottom traces) Currents during voltage steps at indicated steady-state cGMP concentrations (tested
as in Fig. 1). (B1–B3) Excerpts of single X-  channel recordings at indicated potentials and steady-state cGMP concentrations (same patch
as in Fig. 4, B1–B4). Popen values from excerpt in 3 mM cGMP are 0.676 at  80 mV and 0.462 at  80 mV; values from excerpt in 30 mM
cGMP (collected at steady-state after onset of desensitization) are 0.131 at  80 mV and 0.125 at  80 mV. (C) Mean dose–response data for
X-  activation by cAMP (closed circles) and cGMP (open circles) at  100 mV, compiled from six patches expressing macroscopic currents;
graph is normalized with Pmax,cAMP   0.49, the mean from single-channel measurements (materials and methods). Lines show Hill equa-
tion ﬁts for cAMP (solid) and cGMP (dashed; excluding data  3 mM); see Table I for values of K1/2 and h. Using ﬁtted values for Imax, the ra-
tio Imax,cAMP/Imax,cGMP is 1.405   0.034. For comparison, X-  dose–response curves for cAMP (solid line) and cGMP (dashed line), taken
from Fig.1 C and normalized as in Fig. 4 C, are shown.533 Young et al. 
derived from a similar structural basis. The mean
  Gsat,cAMP for X-  is more positive (i.e., less favorable)
than that of X-  by  13 kJ/mol (P   0.0002). An ad-
ditional observation comes from the cAMP dose–
response curve for macroscopic X-  currents: X-  has a
higher K1/2 and a lower Hill coefﬁcient than X-  (Fig. 4
C). Therefore, in terms of both sensitivity and efﬁcacy,
cAMP is a poorer agonist for X-  than for X- .
X-  activation by cGMP at low concentrations resem-
bles activation by similar concentrations of cAMP, but
upon exposure to cGMP concentrations of 10 mM or
higher the elicited macroscopic current decays in ampli-
tude to a steady-state level that is lower than that elicited
by 3 mM cGMP (Fig. 5 A; compare current traces in 3
mM cGMP and 30 mM cGMP). This indicates that the
channels enter a desensitized state; entry to and exit
from the desensitized state occur faster than the rate at
which solutions are exchanged by the perfusion system
(within a few seconds). This phenomenon is also found
in homomeric channels composed of intact fCNG2 sub-
units (Goulding et al., 1992) but until now has not been
examined closely. Desensitization of X-  is not relieved
by positive voltage and does not change the extent of
outward rectiﬁcation, which remains slight, as seen for
X-  (Fig. 5 A, voltage step traces). Note that there is no
evidence for this desensitization in X-  when cAMP is
the agonist (up to 30 mM), nor in X-  when either
cAMP or cGMP is the agonist (up to 30 mM). Single-
channel recordings show that desensitization does not
result from an altered single-channel conductance (see
30 mM cGMP trace, Fig. 5 B3; unpublished all-points
histograms) but rather from a decrease in open proba-
bility. Thus, the dose–response curve of steady-state
Popen versus cGMP concentration shows a maximum at
 3 mM, with a decrease in Popen at a higher agonist con-
centration (Fig. 5 C). K1/2,cGMP was determined only for
the rising phase of the dose–response curve, using data
collected at cGMP concentrations  3 mM. Similarly,
the maximum open probability (Pmax,cGMP) was mea-
sured at only 3 mM in single-channel recordings, with a
mean of 0.25   0.28 (n   9). When these Pmax measure-
ments are converted to free energies, the mean  G-
sat,cGMP is  4.0   4.8 kJ/mol (n   9). Although we retain
the “max” and “sat” subscripts in the efﬁcacy symbols,
we emphasize that the Pmax,cGMP values and  Gsat,cGMP val-
ues do not measure opening energetics for X-  chan-
nels with binding sites saturated by ligand, but are em-
pirical measures of the highest observable open proba-
bility on the cGMP dose–response curve.
Because of cGMP-dependent desensitization, compar-
isons of cAMP and cGMP activation using conventional
parameters like Pmax (or  Gsat) and K1/2 cannot be inter-
preted mechanistically for X-  as they can for X- . Nota-
bly, for X-  the parameters  Gsat,cGMP and  Gsat,cAMP
characterize channels at different degrees of binding
site saturation, so they cannot be directly compared or
used to calculate the efﬁcacy selectivity,  Gsel, for quan-
titative comparison with the  Gsel of X- . Nonetheless,
comparisons of Pmax or of K1/2 do provide empirical de-
scriptions of the agonist selectivity of X- . When cAMP
and cGMP activation are compared at a given high (mil-
limolar) concentration, desensitization is marked and
Popen is much higher in cAMP than in cGMP; thus X- 
channels can be described as selective for cAMP. Speciﬁ-
cally, Pmax,cAMP (measured at saturating cAMP concentra-
tions) was greater than Pmax,cGMP (measured at 3 mM,
the peak of the dose–response curve) in every single-
channel patch for which both these measurements were
made; the mean ratio Pmax,cAMP/Pmax,cGMP was 2.3   1.7
(n   6). The ratio of open probabilities in cAMP and
cGMP is even greater than this factor when cGMP con-
centrations higher than 3 mM are considered. In con-
trast, when agonist concentration is decreased below
millimolar levels, desensitization is not apparent, and
X-  exhibits a reversal of selectivity (crossing of dose–
response curves) so that cGMP produces a higher Popen
than does cAMP. This cGMP selectivity is reﬂected
empirically in the low K1/2 selectivity ratio (K1/2,cGMP/
K1/2,cAMP   0.407   0.026; Fig. 5 C).
Table I summarizes and compares activation parame-
ters for the two new chimeras as well as for ROON-S2.
Each chimera combines a different BD sequence with
an invariant non-BD sequence (”X-”), and each was
tested as a homomeric channel, like a conventional  
subunit. The functional differences among the chime-
ras, hence, can be attributed wholly to differences in
how their respective BDs interact with agonist and/or
with the invariant non-BD regions. One way to com-
pare BDs is to examine how efﬁciently a given agonist
like cAMP activates each X-chimera: of the three chi-
meras, X-  (containing the BD of the   subunit
rCNG5) shows the most efﬁcient cAMP activation (the
lowest K1/2 and highest Pmax), and X-  shows the least
efﬁcient activation. Thus, not only can the BD of
rCNG5 participate in cAMP activation of a homomeric
channel, but it also can do so with higher efﬁciency
than the BDs of the   subunits bCNG1 and fCNG2.
Note that any ranking of BDs by activation efﬁciency
will depend on which agonist is considered: the chi-
mera most efﬁciently activated by cGMP is not X-  but
ROON-S2 (with the BD of bCNG1).
Another way to compare the three BDs is to examine
the selectivity for one agonist over another in each
X-chimera. The chimera X-  shows for the ﬁrst time
that in a homomeric channel, the rCNG5 BD imparts
selectivity for cAMP over cGMP, as measured by both ef-
ﬁcacy and K1/2. This agrees with observations that a hall-
mark modulatory effect of assembly of intact rCNG5 in
   channels is an enhancement of cAMP activation
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(Bradley et al., 1994; Liman and Buck, 1994; Finn et al.,
1998). In contrast, the bCNG1 BD imparts to ROON-S2
a strong selectivity for cGMP, just as it does in intact
bCNG1 homomers (Kaupp et al., 1989; Altenhofen et
al., 1991; Goulding et al., 1994). The cGMP-dependent
desensitization observed in X-  mimics that found in
intact fCNG2 homomers (Goulding et al., 1992).
Therefore, in general, the BDs in the X-chimeras show
selectivities that reﬂect those of the intact subunits
from which they are derived.
The very existence of agonist selectivity in the X-chi-
meras implies that the interaction of agonist with the
BD is structurally speciﬁc. Previous studies (Varnum et
al., 1995; Scott and Tanaka, 1998; Sunderman and Za-
gotta, 1999; Pagès et al., 2000; Shapiro and Zagotta,
2000; He and Karpen, 2001) found that agonist selec-
tivity in both   homomers and    heteromers is
strongly inﬂuenced by the amino acid at position 604
in the C-helix subdomain (numbering is based on
bCNG1; see materials and methods). At this posi-
tion, aspartate (found in bCNG1) and methionine
(found in rCNG5) imparted cGMP- and cAMP selectiv-
ity, respectively, to bCNG1 homomers (Varnum et al.,
1995; Sunderman and Zagotta, 1999). That ﬁnding is
borne out in the current study, since ROON-S2 (with
aspartate at position 604) is cGMP-selective and X- 
(with methionine) is cAMP-selective. The fCNG2 BD in
X-  has a glutamine at position 604; this amino acid
was previously found to impart weak cGMP selectivity to
bCNG1 homomers (Varnum et al., 1995; Sunderman
and Zagotta, 1999). Although evaluation of selectivity
in X-  is complex because of desensitization (see previ-
ous page), this channel is indeed selective for cGMP at
low agonist concentrations where desensitization is less
likely to be a confounding factor. Therefore, the ago-
nist selectivity in all three chimeras is correlated with
the amino acid identity at position 604 as previously
characterized. This correlation suggests strongly that
the structures of the BDs in the X-chimeras closely re-
semble those found in previously studied intact   sub-
units, and more generally, the mechanism of ligand-
gating in the X-chimeras reﬂects the canonical mecha-
nism of wild-type CNG channels.
The putative C-helix subdomain, which contains resi-
due 604, has been assigned a key role in some models
of how the BD functions during ligand-gating of CNG
channels. Previous studies suggested that coupling en-
ergy for channel activation depends largely on a con-
tact between the C-helix and the ligand which is stron-
ger in the open than in the closed state of the channel
(Goulding et al., 1994; Varnum et al., 1995; Sunderman
and Zagotta, 1999). It has moreover been proposed
that the C-helix undergoes a large rigid-body rotation
during channel activation (Matulef et al., 1999). In
contrast the roll subdomain has been proposed to
make state-independent contacts that contribute ligand
TABLE I
Activation Properties of CNG Channel Subunit Chimeras Differing only in BD Sequences
Chimera X-  X-  ROON-S2c
BD source rCNG5 fCNG2 bCNG1
Macroscopic
current
Hill equation 
parameters K1/2,cAMP 81    85 (9)  643   29a 432   99 (4)
K1/2,cGMP 120    140 (9)   261   12 1.8   1.0 (10)
hcAMP  2.14   0.26 (9) 1.123   0.070  1.31   0.34 (4)
hcGMP 2.07    0.27 (9) 1.210   0.046  1.89   0.38 (10)
K1/2 selectivity
ratio K1/2,cGMP/K1/2,cAMP 1.45   0.13 (9) 0.407   0.026 0.0042   0.0025b 
Single channel Pmax,cAMP 0.980    0.025 (6) 0.49   0.30 (9) 0.98d
Pmax,cGMP 0.947    0.068 (5) 0.25   0.28 (9)  0.9987   0.0021 (5)
 Gsat,cAMP   12.8   5.6 (6)  0.1   4.1 (9)  9.6d
 Gsat,cGMP   9.5   4.8 (5)  4.0   4.8 (9)  18.7   3.6 (5)
Efficacy 
selectivity  Gsel   4.2   1.7 (5) n.d.  9.1d
Except where otherwise noted, all entries are means   SD of values evaluated in individual patches (number of patches is given in parentheses). Selectivity
ratio above unity or efficacy selectivity below zero corresponds to selectivity for cAMP over cGMP. Units are  M for K1/2 values and kJ/mol for  G values.
aAll parameters for X-  macroscopic current are derived from a composited pool of six patches (see materials and methods) excluding data from  3
mM cGMP; Hill parameters are given   SEM.
bSelectivity ratio calculated from ratio of entries for K1/2 in this table.
cData for ROON-S2 from Tibbs et al. (1997, 1998).
dDerived from assuming that Pmax,cAMP   Imax,cAMP/Imax,cGMP as measured from macroscopic currents.535 Young et al. 
binding energy but not coupling energy toward activa-
tion, so that the BD has a “functional polarity” (Tibbs et
al., 1998). The two BD sequences of fCNG2 and rCNG5
diverge far less in the roll subdomain (89% similarity)
than in the C-helix (64% similarity). This fact, along
with the correlation between the identity of residue 604
and agonist selectivity in our BD chimeras, suggested to
us that sequence variation in the C-helix might also be
the primary determinant of the absolute differences in
agonist efﬁcacy between X-  and X- .
High Activation Efﬁciency of X-  Compared with X-  Cannot 
Be Attributed Solely to C-helix Residues
We constructed two new chimeras to ask whether differ-
ences in absolute activation efﬁcacy ( Gsat) and in sensi-
tivity (K1/2) between X-  and X-  were wholly due to dif-
ferences in their C-helix sequences or if other elements,
such as the roll subdomain, also contribute. The ﬁrst chi-
mera, X- R/ C, has a BD comprising the roll subdomain
(denoted by “R”) from the   subunit fCNG2 and the
C-helix (denoted by “C”) from the   subunit rCNG5.
The second chimera, X- R/ C, is complementary in or-
ganization, with a BD comprising the roll subdomain
from the   subunit and the C-helix from the   subunit.
Because of the prominence of the C-helix in previous
models, we expected that activation of X- R/ C would
be similar to X- , or at least signiﬁcantly better than
X- , but this is far from the case. We ﬁnd (to our sur-
prise) that the C-helix of rCNG5 contains sequence ele-
ments with a markedly negative inﬂuence on channel
activation. X- R/ C exhibits cGMP-dependent desensi-
tization similar to that of X- , so cAMP activation will
be discussed ﬁrst. Single-channel recordings for X- R/
 C show very low Popen even at high cAMP concentra-
tions (Fig. 6 A1). The mean Pmax,cAMP is 0.056   0.091
(n   6), which is ninefold lower than that of X- . In
thermodynamic terms, the mean  Gsat,cAMP is  9.2  
3.6 kJ/mol (n   6). Note that the Pmax values for X- R/
 C have a SD that is larger than the mean (the range of
values is 0.0047–0.27), whereas the SD of  Gsat,cAMP val-
ues is smaller than the mean. This is consistent with the
highly nonlinear relationship between  Gsat and Pmax
since Pmax is very low for this chimera. For example, a
relatively small variation of 2 kJ/mol in  Gsat corre-
sponds to a variation in Pmax which is very small ( 1%)
if Pmax   0.99 as for X- , but large ( 50%) if Pmax   0.5
as for X- , and enormous ( 100%) if Pmax   0.05 as for
X- R/ C. The variation in efﬁcacies of single X- R/ C
channels is similar in energetic terms ( Gsat,cAMP has a
spread of  11 kJ/mol) to those found for X-  and X- ,
whereas the means of the three chimeras are widely
separated. Speciﬁcally, the mean  Gsat,cAMP for X- R/ C
is more positive (i.e., less favorable) than that of X-  by
 9 kJ/mol (P   0.0002).
Because a patch that appears to contain a single chan-
nel may actually contain more than one if Pmax is very
low, the “single-channel” experiments provide only an
upper limit for the true Pmax of X- R/ C. In the patch
shown in Fig. 6 A1, Pmax in saturating cAMP was potenti-
ated to a value close to 1 by application of the allosteric
modulator Ni2  (Ildefonse et al., 1992; Gordon and Za-
gotta, 1995b), conﬁrming that a single channel was
present. To obtain an independent estimate of Pmax that
does not depend on knowing the number of channels in
the patch, we measured the extent of potentiation of
macroscopic X- R/ C currents by Ni2  in the presence
of saturating concentrations of cAMP (Varnum et al.,
1995). The ratio of the current elicited without Ni2  to
the current elicited with Ni2  (Imax,cAMP/Imax,cAMP Ni) pro-
vides an estimate for Pmax,cAMP; this estimate, like that
from single-channel experiments, is an upper limit since
Ni2  may not increase Pmax to 1. For X- R/ C, this ratio is
0.071   0.010 (n   8), similar to Pmax,cAMP from single-
channel recordings. In contrast, X-  currents gave a ra-
tio Imax,cAMP/Imax,cAMP Ni   0.38   0.17 (n   8), which is
consistent with the Pmax values from single X-  channel
recordings. Thus, two different approaches show that
the cAMP activation of X- R/ C has a lower efﬁcacy, not
higher efﬁcacy, compared with that of X- . An addi-
tional indicator that X- R/ C activates less efﬁciently
than X-  is that the K1/2,cAMP of X- R/ C (Fig. 6 A2) is
higher than that of X-  (Fig. 4 C and Table I). There-
fore, replacing the fCNG2 C-helix sequence in X-  with
the rCNG5 C-helix sequence has a deleterious effect on
both the efﬁcacy and sensitivity of cAMP activation.
The activation of X- R/ C by cGMP is even less efﬁ-
cient than its activation by cAMP. The cGMP dose–
response curve from macroscopic current experiments
is biphasic (like that of X- ) with desensitization above
3 mM, so that at high agonist concentrations X- R/ C
exhibits markedly larger currents in cAMP than in
cGMP (Fig. 6 A2). The maximal cAMP-activated current
(Imax,cAMP, measured at saturating cAMP concentrations)
is greater than the maximal current for cGMP activation
(Imax,cGMP, measured at 3 mM, the peak of the dose–
response curve) by a factor of 2.85   0.30 (n   4). The
cAMP selectivity is not limited to the concentration re-
gime where cGMP-dependent desensitization is appar-
ent: even at the lowest tested agonist concentrations,
cAMP elicits larger X- R/ C currents than does cGMP.
The Pmax in 3 mM cGMP was not measured in single
X- R/ C channel recordings; however, assuming the ra-
tio Imax,cAMP /Imax,cGMP in macroscopic currents measures
the true ratio of Pmax,cAMP /Pmax,cGMP for each single-
channel patch, we calculate that Pmax,cGMP values would
have a range from 0.0017 to 0.10, and a mean of 0.020;
these Pmax,cGMP values for X- R/ C are  10-fold lower
than those for X- , indicating that like cAMP activation,
cGMP activation is made less efﬁcient by the replace-
ment of the fCNG2 C-helix with the rCNG5 C-helix.536 Efficient Coupling by a CNG Channel   Subunit Binding Domain
Figure 6. Chimera X- R/ C is poorly activated by cyclic nucleotide, whereas the complementary chimera X- R/ C is efﬁciently activated by
cyclic nucleotide. (A1) X- R/ C contains the roll subdomain from fCNG2 and the C-helix from rCNG5. Single-channel recordings were made
at indicated potentials with a steady-state concentration of 30 mM cAMP, with or without 5  M Ni2  present. (top traces) Pmax is low in absence
of Ni2  (Popen   0.004 at  80 mV and 0.012 at  80 mV). (bottom traces) Channel opening is potentiated by Ni2 , showing only one channel
is present (Popen   0.874 at  80 mV and 0.878 at  80 mV). (A2) Mean dose–response data for X- R/ C activation by cAMP (closed circles)
and cGMP (open circles) at  100 mV, compiled from four patches expressing macroscopic currents (materials and methods); graph is
normalized using Pmax,cAMP   0.056, the mean from single-channel measurements. Lines show Hill equation ﬁts with parameters ( SEM) as
follows: for cAMP (solid), K1/2   1,570   370  M, h   0.932   0.065; for cGMP (dashed, excluding data  3 mM), K1/2   511   37  M, h  
1.120   0.044; Imax,cAMP/Imax,cGMP   2.85   0.30. (B1) X- R/ C contains the roll subdomain from rCNG5 and the C-helix from fCNG2. Single-
channel recording excerpt (no Ni2  present) shows high Pmax in 30 mM cAMP (Popen   0.9878 at  80 mV and 0.9896 at  80 mV). (B2)537 Young et al. 
We were wary that the unexpectedly poor activation of
X- R/ C might indicate merely that its chimeric BD was
grossly misfolded. However, several lines of evidence ar-
gue that the BD of X- R/ C is similar to intact BDs in
structural organization. First, cAMP activates homomers
of intact bCNG1 with low efﬁcacy, so low efﬁcacy is not
in itself an absolute indicator of BD misfolding. Second,
single channels of X- R/ C can indeed achieve high lev-
els of cyclic nucleotide-dependent activation when po-
tentiated by Ni2 . This reagent acts through binding to
the C-linker region and so is not expected to inﬂuence
the folding of the BD structure directly (Gordon and
Zagotta, 1995b). Third, X- R/ C mimics X-  (and intact
fCNG2) in exhibiting desensitization in high concentra-
tions of cGMP but not cAMP, implying that these sub-
units have BDs with similar structures. Fourth, the selec-
tivity for cAMP over cGMP of X- R/ C is strong over all
agonist concentrations, as predicted from the presence
of M604 in the rCNG5 C-helix. It is unlikely that a mis-
folded BD could preserve the speciﬁc interaction of
ligand with the C-helix residue that is believed to impart
this selectivity (Varnum et al., 1995). All evidence sup-
ports the conclusion that X- R/ C has a BD whose struc-
ture closely resembles that of BDs in intact subunits, but
that at some functionally important position(s) in the
BD sequence, X- R/ C has an amino acid that decreases
the efﬁciency of ligand-gating.
Another simple interpretation of the poor efﬁcacy of
activation of chimera X- R/ C might be that the rCNG5
C-helix sequence is not inherently unfavorable for acti-
vation compared with the fCNG2 C-helix sequence, but
rather that mixed pairing of subdomains from   and  
subunits would always have a deleterious effect on acti-
vation energetics. This interpretation cannot be correct,
however, because X- R/ C, which has a mixed pair of
subdomains complementary to X- R/ C, shows a very
high efﬁcacy of activation. In single-channel recordings
(Fig. 6 B1), X- R/ C has a high efﬁcacy for both
agonists (Pmax,cAMP   0.954   0.056 and  Gsat,cAMP  
 10.6   5.8 kJ/mol, n   5; Pmax,cGMP   0.92   0.12 and
 Gsat,cGMP    10.1   6.0 kJ/mol, n   6). In particular,
the mean  Gsat,cAMP efﬁcacy of X- R/ C is signiﬁcantly
more favorable than that of X-  (which has an intact
fCNG2 BD) by  10 kJ/mol (P   0.002). Thus mixing
subdomains from   and   subunits cannot be predicted
to have a positive or negative effect on activation ener-
getics as a general rule. To summarize the results from
the group of four chimeras, both X-  and X- R/ C show
relatively low efﬁcacy of activation with either cAMP or
cGMP, whereas both X-  and X- R/ C show relatively
high efﬁcacy of activation with either agonist. Conse-
quently the C-helix cannot be reckoned the sole major
BD determinant of the absolute extent of activation in
CNG channels, since efﬁcacy in the four chimeras does
not correlate with the identity of the C-helix subdo-
main. Rather, the efﬁcacy correlates with the identity of
the roll subdomain: low efﬁcacy derives from the fCNG2
sequence and high efﬁcacy from the rCNG5 sequence.
Moreover, the C-helix is also not the sole determi-
nant of the relative extent of activation by different ag-
onists, i.e., agonist selectivity. X-  and X- R/ C both
contain the same C-helix sequence (from fCNG2), but
X- R/ C fails to show the cGMP-dependent desensitiza-
tion seen in X- . This means that the roll subdomain of
the   subunit (fCNG2) is responsible for desensitiza-
tion, an unusual but nonetheless agonist-speciﬁc deter-
minant of open probability. Therefore, the roll subdo-
main sequence can contain residues that exert large ef-
fects on agonist selectivity as well as absolute open
probability at high agonist concentrations.
Although the above results show that the C-helix is
not the sole determinant of agonist selectivity, at the
same time, they do conﬁrm that the C-helix does in-
deed contribute important determinants of selectivity.
Thus, X-  and X- R/ C differ only in their C-helix se-
quences, and show a different selectivity. In terms of ef-
ﬁcacy, X-  exhibits strong cAMP selectivity (see  Gsel in
Table I, and Fig. 7 A), whereas X- R/ C does not select
among the two agonists, with a very small  Gsel value
( 1.1   3.2 kJ, n   5;  Gsel values for the two chimeras
are signiﬁcantly different, P   0.02). The difference be-
tween the chimeras is even more pronounced at low
(submillimolar) agonist concentration, where X-  is se-
lective for cAMP, but X- R/ C is selective for cGMP (see
dose–response curves, Fig. 1 C and Fig. 6 B2). The ratio
K1/2,cGMP/K1/2,cAMP was tested in individual macroscopic
current patches of X- R/ C (as was done for X- ) and
was  1 in every case, with a mean of 0.420   0.095, n  
8 (indicating signiﬁcant cGMP selectivity, P   0.002).
This is signiﬁcantly different (P   0.0001) from the K1/2
ratio of X-  (1.45   0.13, n   9; Fig. 7 B). In general, at
submillimolar agonist concentrations, the chimeras
containing the rCNG5 C-helix (X-  and X- R/ C) are
cAMP-selective and the chimeras containing the fCNG2
C-helix (X-  and X- R/ C) are cGMP-selective. These
selectivities are consistent with the respective identities
of residue 604 in the two chimeras.
Efﬁcacy Determinants Inside and Outside the C-helix 
Do Not Act Independently
The above results show that differences in activation
properties of X-  and X-  are derived from elements in
Dose–response data for X- R/ C activation by cAMP (solid circles)
and cGMP (open circles) at  100 mV, from a patch with maximal
current  400 pA; graph is normalized using Pmax,cAMP   0.954, the
mean from single-channel measurements. Lines show Hill equation
ﬁts with parameters ( SE) as follows: for cAMP (solid), K1/2  
288   20  M, h   1.37   0.12; for cGMP (dashed), K1/2   95.8  
9.2  M, h   1.95   0.22; Imax,cAMP/Imax,cGMP   1.0078   0.030.538 Efficient Coupling by a CNG Channel   Subunit Binding Domain
both the C-helix and roll subdomains. Do these two re-
gions act independently or do they interact during acti-
vation of the channel? If these subdomains act inde-
pendently of one another, then their energetic contri-
butions to channel activation will be invariant when
quantiﬁed separately and will be strictly additive. This
independence hypothesis can be tested by thermody-
namic linkage analysis of the four chimeras we have
studied here (Fig. 8; see materials and methods),
which form corners of a linkage cycle (Wyman, 1964;
Weber, 1975); the chimeras represent all combinations
of the roll and C-helix subdomains from fCNG2 and
rCNG5. Thus, if the C-helix acts independently of the
roll subdomain, we would predict that the effects on ac-
tivation of exchanging the   subunit C-helix for the  
subunit C-helix should be the same whether we mea-
sure the difference in activation between X-  and
X- R/ C or whether we measure the difference in acti-
vation between X- R/ C and X-  (see Fig. 8 B, double
arrows). (The same principles have been applied to
point mutations in “double mutant cycle” analysis
[Carter et al., 1984; Scott and Tanaka, 1998].)
We ﬁnd that the two subdomains do not act indepen-
dently, as shown in Fig. 8 and Table II, which summarize
activation efﬁcacy ( Gsat) and other activation parame-
ters for the corners of the linkage cycle. We consider
only cAMP efﬁcacy because its analysis is not compli-
cated by desensitization. Converting X-  into X- R/ C
(Fig. 8 B, double arrow on left side of cycle) leads to a
decrease in efﬁcacy (the difference in  Gsat,cAMP is
   Gsat,cAMP    9.3 kJ/mol, and is statistically signiﬁ-
cant, P   0.0002). In this sequence substitution, the
C-helix of the   subunit appears to have a deleterious
effect on activation. (Allowing the possibility that the
Pmax,cAMP of X- R/ C may be overestimated by single-
channel recordings and Ni2  potentiation experiments,
the deleterious effect of the rCNG5 C-helix may be even
greater than we report.) However, making the same
C-helix replacement in the conversion of X- R/ C into
X-  (Fig. 8 B, double arrow on right side of cycle) has
little effect on efﬁcacy (  Gsat,cAMP    2.2 kJ/mol, which
is not a signiﬁcant change in  Gsat,cAMP, P   0.6), as if the
deleterious effect of the rCNG5 C-helix has been miti-
gated. This is inconsistent with the independence hypoth-
esis; i.e., the contributions made by the C-helix and roll
subdomains toward cAMP activation are not independent
but are energetically coupled. This implies that subdo-
main interaction contributes to preferential open state
stabilization in at least one of the four chimeras.
To restate our analysis: when the   subunit BD is re-
placed with the   subunit BD (converting X-  to X- ),
the absolute opening efﬁcacy for cAMP activation
(  Gsat,cAMP) is strongly enhanced (  Gsat,cAMP between
X-  and X-  is negative). Both subdomains contain se-
quence elements that inﬂuence efﬁcacy, because re-
placements of each of the major subdomains alone also
change  Gsat,cAMP. However, a simple summation of the
efﬁcacy changes (  Gsat,cAMP) produced by individual
subdomain replacements cannot account for all of the
  Gsat,cAMP between X-  and X- . The discrepancy (the
portion of the   Gsat,cAMP between X-  and X-  that re-
mains not accounted for) can be termed “interaction
coupling energy,” because it can exist only if one or
more of the four possible subdomain pairs ( R/ C,
 R/ C,  R/ C, or  R/ C) contains an interaction be-
tween subdomains. The subdomain interaction respon-
sible for interaction coupling energy must change in
strength during the channel opening transition, and if
it occurs in all four subdomain pairs, then it cannot be
identical in all pairs.
Note that interaction coupling energy is distinct from
the “activation coupling energy” previously discussed.
Figure 7. Chimeras X- R/ C and X-  exhibit different agonist
selectivity. (A) Points plot the efﬁcacies of the two chimeras ob-
tained from single-channel patches from distinct oocytes. Each
vertical line connects a solid and an open point plotting data for
cAMP and cGMP, respectively, obtained from an individual patch.
For some patches, efﬁcacy was only measured for one agonist so
only one point is plotted without a vertical line. Efﬁcacies are plot-
ted as  Gsat (left axis) or equivalently as Pmax/(1   Pmax) on a loga-
rithmic scale (right axis). (B) Points plot the K1/2 values of the two
chimeras obtained from macroscopic current patches from dis-
tinct oocytes, with cAMP and cGMP data represented as in A.539 Young et al. 
The activation coupling energy is a property of an indi-
vidual chimera, and represents the portion of  Gsat,cAMP
that is contributed by interactions of the BD with the ag-
onist molecule. The interaction coupling energy is a
property of the set of four subdomain pairs (roll  
C-helix) formed from two given BD sequences (e.g.,
Figure 8. Analysis of cAMP activation data for chimeras using a thermodynamic linkage cycle. (A) Efﬁcacies of cAMP activation for all
single-channel patches in this study are plotted using the same axes as in Fig. 6 A; each solid point plots data obtained from an individual
patch from a distinct oocyte. (B) BDs of four chimeras arranged at the corners of the linkage cycle. Wide arrows represent replacements of
fCNG2 C-helix by rCNG5 C-helix; dashed arrows represent replacements of fCNG2 roll subdomain by rCNG5 subdomain. For each re-
placement,   Gsat,cAMP (deﬁned as the change in  Gsat,cAMP that results from performing that replacement) is shown, in units of kJ/mol.
The independence hypothesis fails because parallel sides of the cycle have different values of   Gsat,cAMP.
TABLE II
Summarized Activation Parameters for Chimeras in Thermodynamic Linkage Relationship
Chimera X-  X- R/ C X- R/ C X- 
cAMP  Gsat   0.1   4.1 (9)  9.2   3.6 (8)  10.6   5.8 (5)  12.8   5.6 (6)
K1/2   643    29a 1,570   370a 222   116 (8) 81   85 (9)
cGMP Desensitization Yes Yes No No
 Gsat  4.0   4.8 (9) n.d.  10.1   6.0 (6)  9.5   4.8 (5)
K1/2   261    12a 511   37a 81   39 (8) 120   140 (9)
Selectivity
Efficacy  Gsel n.d. n.d.  1.1   3.2 (5)  4.2   1.7 (5)
 K 1/2 K1/2,cGMP/K1/2,cAMP 0.407   0.026a 0.325   0.080a 0.420   0.095 (8) 1.45   0.13 (9)
Except where otherwise noted, all entries are means   SD of values evaluated in individual patches (number of patches is given in parentheses). Units are
 M for K1/2 values and kJ/mol for  G values.
aDerived from composited pools of six patches for X-  and four patches for X- R/ C (see materials and methods), excluding data from  3 mM cGMP;
K1/2 uncertainties are  SEM.540 Efficient Coupling by a CNG Channel   Subunit Binding Domain
fCNG2 and rCNG5). It represents the contribution of
subdomain interactions toward the variation in  Gsat,cAMP
among the four subdomain pairs. Quantitative determi-
nation of interaction coupling energy for cAMP activa-
tion ( Gint,cAMP) is done simply by taking the difference
between parallel sides of the linkage cycle, ( 2.2)   
( 9.3)   ( 22.0)   ( 10.5)    11.5 kJ/mol. Under
the sign convention used here (Weber, 1975), the nega-
tive sign of  Gint,cAMP indicates that the most favorable
contribution to cAMP activation from the interaction oc-
curs when both subdomains derive from the same iso-
form rather than from different isoforms.
DISCUSSION
The   Subunit BD Is Functional
The CNG channel subunit rCNG5 is classed as a modu-
latory or   subunit because it contains some as yet un-
identiﬁed “defects” in its structure that prevent assembly
of homomeric channels that can be activated by cyclic
nucleotide. Interaction with an   subunit neutralizes
the defects, so heteromeric    channels are fully func-
tional. Paradoxically, the defects coexist in the   subunit
with elements that contribute favorably to cyclic nucle-
otide activation, so that    heteromeric channels acti-
vate with greater sensitivity to cyclic nucleotide than do
  homomers. This study provides strong evidence that
the residues responsible for failure of the   subunit to
form functional homomers lie outside the cyclic nucle-
otide binding domain. This conclusion is based on our
demonstration, for the ﬁrst time, that the BD of the  
subunit rCNG5 participates in coupling of ligand bind-
ing to channel opening in a homomeric CNG channel
that does not contain residues from   subunit BDs. If in-
teractions between BDs are important for ligand-gating
as has been proposed, these interactions can occur be-
tween rCNG5 BDs in the same manner as they occur be-
tween   subunit BDs. Possibly the failure to form func-
tional   homomers might be due to a deleterious inter-
action (or the lack of a required interaction) between
the   subunit BD and   subunit non-BD regions; how-
ever, the “defective” residues in this partnership must be
those of the   subunit non-BD regions rather than those
of the   subunit BD, since in our work the   subunit
non-BD regions can interact properly with the   subunit
BD to form functional homomers.
We went further with a comparative study of a series
of chimeras containing different BD sequences from ei-
ther   or   subunits. All the chimeras shared an identi-
cal non-BD sequence so functional differences must be
derived from BD sequence polymorphism. We found
that when cAMP is used as an agonist, the chimera
(X- ) containing the BD of the   subunit rCNG5 is
more efﬁciently activated than are two other chimeras
containing BDs from the   subunits bCNG1 or fCNG2.
When cGMP is the agonist, the activation of the   sub-
unit BD chimera also far surpasses that of the fCNG2
BD chimera, although the rCNG5 BD chimera is acti-
vated less well than the chimera containing the BD of
bCNG1. Thus, the   subunit BD certainly contains no
defect that precludes ligand-gating, and rather contains
structural elements that are highly favorable to channel
activation in comparison to BDs from some   subunits.
The functional capability of the   subunit BD was ad-
dressed in a previous study (Shapiro and Zagotta,
2000) using chimeras derived from the   subunit
rCNG2 and the same   subunit rCNG5 that we used. In
that study, a chimeric CNG channel subunit,  -CNBR ,
was constructed, consisting of the   subunit with its BD
sequence replaced by that of the   subunit (a composi-
tion complementary to our chimera X- ). It was found
that   -CNBR  failed to form functional homomeric
channels but did coassemble with   subunits to form
functional heteromeric channels. This showed that the
  subunit sequence outside of the BD contains defects
that prevent formation of functional homomeric chan-
nels, but did not argue for or against the presence of an
additional defect in the   subunit BD. Another chi-
mera from that study was composed of the   subunit
rCNG2 in which the BD sequence was replaced with
that of the   subunit rCNG5. Even though this (un-
named) chimera had a similar design to that of X-  in
our study, it failed to form functional channels, either
alone or as heteromers with   subunits, which might be
taken to suggest that the   subunit BD was indeed de-
fective in some way. The activity of X-  in our study de-
ﬁnitively rules out a BD defect; an explanation for the
previous study’s negative result might be a suppres-
sion of channel expression due to some combination
of rCNG2 and rCNG5 residues that conﬂicted with
polypeptide folding. An ongoing search for deﬁcient
regions of the   subunit can, after our study, be limited
to sequence outside of the BD.
Both Subdomains of the BD Determine Efﬁcacy
Another ﬁnding of this study concerns the individual
contributions of two putative subdomains of the   sub-
unit BD, namely the roll subdomain ( -roll with ﬂank-
ing A- and B-helices), and the C-helix. We replaced each
subdomain in the fCNG2 BD with the respective subdo-
main of rCNG5, and found that both swaps had signiﬁ-
cant effects on activation properties. Although the im-
portance of the C-helix in controlling selectivity and ef-
ﬁcacy is well studied, a comparably large inﬂuence of
the roll subdomain has not previously been reported for
CNG channels. Recent evidence suggests that important
control elements for activation do exist in the roll sub-
domains of HCN (pacemaker) channels (Wainger et al.,
2001) and hERG channels (Cui et al., 2000, 2001).541 Young et al. 
Our analysis of chimeric subunits, like that of any
mutagenesis study, depends on the assumption that all
of our chimeras resemble intact CNG channel subunits
in structure and in activation mechanism. We veriﬁed
that multiple functional properties of our chimeras
replicate phenomena observed in intact CNG chan-
nels. Most obviously, the chimeras exhibit cyclic nucle-
otide activation with C-helix–dependent agonist selec-
tivity; in addition, the chimeras replicate the P-loop–
dependent single-channel conductance behavior and (in
the case of X-  and X- R/ C) the BD-dependent desen-
sitization in high cGMP concentration that are found
in the intact CNG channels from which the chimeras
are derived. X-  and X- R/ C exhibit relatively low efﬁ-
cacy in cAMP as do intact homomers of bCNG1 and
fCNG2 (Altenhofen et al., 1991; Goulding et al., 1992),
and this efﬁcacy is increased by the binding of Ni2  to
the C-linker of bCNG1 (Gordon and Zagotta, 1995b)
that is present in all the X-chimeras. (Ni2  also potenti-
ates X-  and X- R/ C, increasing the Popen observed at
subsaturating cyclic nucleotide concentrations; unpub-
lished data). Although no amount of observation could
prove beyond doubt that all aspects of normal CNG
channel structure and mechanism are intact in the
X-chimeras, there is no aspect of X-chimera function
that is not also found in intact CNG channels. Thus,
the assumption that X-chimeras resemble intact CNG
channels seems reasonable.
In our comparison of the fCNG2 and rCNG5 BDs,
the phenotypes of high and low efﬁcacy were corre-
lated with the presence of the roll subdomain of
rCNG5 and fCNG2, respectively, whereas the efﬁcacy
was not correlated with the identity of the C-helix.
Swapping the roll subdomain sequence has a surpris-
ingly large inﬂuence on activation (as much as 22 kJ/
mol change in  Gsat). Earlier studies of residues in the
roll subdomain typically showed only small efﬁcacy ef-
fects: data in the literature (expressed on a free en-
ergy basis under the minimal two-state model) show
changes in  Gsat,cAMP of  4 kJ/mol for the mutation
T560A (Varnum et al., 1995),  1 kJ/mol for F533Y
(Scott and Tanaka, 1998), or  2 kJ/mol for the cova-
lent modiﬁcation of C505 by thimerosal (Matulef et al.,
1999). The most prominent effects of roll subdomain
mutations were in K1/2 values. Indeed, the highly con-
served residue R559 was mutated to a variety of amino
acids with  1,000-fold shifts in K1/2 but no observed ef-
fects on efﬁcacy (Tibbs et al., 1998).
These previous results were generalized in the con-
cept of “functional polarity” in the agonist binding site
(Tibbs et al., 1998), whereby the sequence in the  -roll
determined the strength of binding of the cyclic phos-
phate and ribose moieties of the agonist, but the pref-
erential stabilization of the open state was wholly deter-
mined by interaction of the C-helix with the purine
base moiety of the agonist. In this model, modifying
the roll subdomain sequence would change the chan-
nel–ligand interactions in the closed and open states to
a similar extent, and thus have no effect on open prob-
ability of a fully liganded channel. This notion has been
expressed both explicitly (Tibbs et al., 1998) and im-
plicitly in models of the lobster-claw variety that picture
the  -roll as an invariant ligand-binding site and the
C-helix as a dynamic element that contacts the ligand
only when the channel opens (Matulef et al., 1999;
Sunderman and Zagotta, 1999). Our ﬁndings do not
contradict the notion that the subdomains may have
different degrees of mobility during channel opening,
and functional polarity is certainly a valid description
for some speciﬁc pairs of residues (such as R559/
D604) in the two subdomains. However, our ﬁndings
provide a counterexample against functional polarity,
and thus show that functional polarity is not an accu-
rate general description of relative contributions of the
complete subdomains to channel activation energetics.
Both Subdomains of the BD Determine Selectivity
Identifying molecular determinants of agonist selectiv-
ity has been a dominant goal of structure–function
studies on CNG channels ever since the ﬁrst analyses of
the BD of CNG channels (Altenhofen et al., 1991;
Goulding et al., 1994). A notable success was identiﬁca-
tion of D604 in the bCNG1 C-helix as a strong determi-
nant of cGMP selectivity (Varnum et al., 1995). Because
the   subunit rCNG5 contains methionine rather than
aspartate at the analogous C-helix position, and be-
cause     heteromers containing rCNG5 show en-
hanced activation by cAMP relative to   subunit ho-
momers, we were interested in characterizing the ago-
nist selectivity of homomeric channels containing BD
residues from the   subunit. Our ﬁndings are consis-
tent with the predicted contribution to selectivity of
methionine at position 604 of the rCNG5 C-helix. X- 
was selectively activated by cAMP, and replacing the
C-helix of rCNG5 with that of fCNG2 (and, thus, re-
placing the methionine at position 604 with a gluta-
mine) removed cAMP selectivity. Oddly, although the
resultant chimera (X- R/ C) was cGMP-selective at low
concentrations (as predicted from the glutamine at po-
sition 604), it showed no signiﬁcant efﬁcacy selectivity
( Gsel) at high concentrations. This illustrates that
there is no uniquely correct way to characterize agonist
selectivity. K1/2 is commonly interpreted as measuring
sensitivity (i.e., the extent to which the channel re-
sponds to low concentrations of agonist), but in gen-
eral K1/2 will be partially determined by ligand interac-
tions with the BD that do not contribute activation cou-
pling energy, and thus do not inﬂuence the open
probability. Hence, the BD of X- R/ C forms stronger
interactions with cGMP than with cAMP, but the higher542 Efficient Coupling by a CNG Channel   Subunit Binding Domain
binding energy with cGMP contributes equally to open
and closed state stability.
Chimeras containing the roll subdomain of the
fCNG2   subunit (X-  and X- R/ C) exhibit an unusual
form of selectivity at high agonist concentration, namely
desensitization by cGMP but not by cAMP. This phe-
nomenon is also seen in intact fCNG2 homomers
(Goulding et al., 1992) and is thus not an artifact arising
from the X-chimera construction. No other form of de-
sensitization has ever been reported in wild-type   ho-
momeric CNG channels. Some point mutations of a
glutamate residue in the pore-forming P-loop were
found to impart desensitization to bCNG1 homomers
(Bucossi et al., 1996), but that desensitization differed
from that seen in this study in several ways: it occurred
to a similar extent at all tested concentrations of cGMP
(10–1,000  M), and the single-channel conductance of
desensitizing channels differed from that of nondesensi-
tizing channels, which is consistent with a change in the
structure of the ion permeation pathway; moreover, re-
covery from desensitization was slow (tens of seconds).
By contrast, in our experiments, desensitization is most
pronounced at concentrations above 3 mM cGMP, and
it does not involve a change in single-channel conduc-
tance, which is consistent with a change in channel gat-
ing without a change in permeation properties; more-
over, recovery from desensitization is relatively fast (sec-
onds time scale). Another form of desensitization,
which occurs when cAMP or cGMP is present at concen-
trations of 100  M or greater, and which has slow recov-
ery, has been reported in    heteromeric CNG chan-
nels (Liman and Buck, 1994), but that phenomenon de-
pends on   subunit residues outside the BD (Shapiro
and Zagotta, 2000), as conﬁrmed by the lack of desensi-
tization in X- . Desensitization in our chimeras arises
from some unidentiﬁed element in the fCNG2 roll sub-
domain. An interesting question for future work is
whether the sequence positions in the fCNG2 roll sub-
domain responsible for cGMP-dependent desensitiza-
tion are identical to those positions in the rCNG5 roll
subdomain responsible for high cAMP efﬁcacy.
A minimal kinetic mechanism for our desensitizing
channels consists of an activating process (transition
from closed nondesensitizing state to open state) and a
desensitizing process (transition from open state to
closed desensitized state). The steady-state Popen values
probably underestimate the efﬁciency of the activating
process, and quantitative delineation of the two pro-
cesses will require analysis of opening and closing kinet-
ics. Nonetheless, we can deduce that the two processes
must be associated with distinct ligand-binding events
because the curves of steady-state Popen versus [cGMP]
are biphasic. (Pmax,cGMP and K1/2,cGMP provide empiri-
cal descriptors only of the rising phase of the dose–
response curves.) For the ligand-binding event associ-
ated with the desensitizing process, BDs containing the
fCNG2 roll subdomain clearly distinguish between cyclic
nucleotides, because binding of cGMP but not cAMP
causes a decrease in open probability. Hence, the roll
subdomain of fCNG2 inﬂuences agonist selectivity in
the desensitizing process. We cannot conclude whether
the roll subdomain also exerts agonist-selective effects
on the activating process, but we note that the differ-
ence between “closed nondesensitizing” and “closed de-
sensitized” states might be nothing more than the num-
ber of cGMP molecules bound to the channel.
We conclude that cAMP selectivity in channel open-
ing can arise not only from the C-helix of the   subunit
rCNG5 as previously predicted, but also from the roll
subdomain of the   subunit fCNG2. Moreover, the lat-
ter subdomain confers a unique form of agonist selec-
tivity: a cGMP-dependent decrease in channel open
probability (desensitization). These two forms of selec-
tivity are not mutually exclusive and, indeed, appear to
be of similar importance in determining the agonist se-
lectivity of a given BD sequence. Hence, either the
fCNG2 roll subdomain or the rCNG5 C-helix subdo-
main is sufﬁcient to make Popen higher in cAMP than in
cGMP over some range of agonist concentration; the
chimera X- R/ C that combines both elements pro-
duces larger currents in cAMP than in cGMP at every
tested concentration. Residues controlling selectivity
for the activating and desensitizing processes may in-
deed turn out to be segregated in the C-helix and roll
subdomains, respectively. Thus, some form of func-
tional polarity may apply to agonist selectivity.
Strong Interaction between BD Subdomains Determines 
Preferential Open State Stabilization
An important and striking ﬁnding is that the molecular
interactions contributed by the rCNG5 C-helix have
widely different effects on activation efﬁcacy, depend-
ing on the sequence of the roll subdomain. This non-
additivity of the effects of subdomain replacement indi-
cates the subdomains are energetically coupled, which
implies that an interaction between them partially de-
termines the relative stability of the channel’s open
state. These interactions may be direct through imme-
diate contact, or indirect through another structural el-
ement, such as the agonist molecule or a non-BD re-
gion. (Note all non-BD regions are conserved in the
chimeras of this study.) The interaction in question de-
pends on some residues that are not conserved be-
tween the fCNG2 and rCNG5 BD sequences (if all resi-
dues pertinent to the interaction were conserved in our
four chimeras, then nonadditivity would not have been
observed). It remains to be seen if nonadditivity effects
can be found for other pairs of BD sequences.
Our analysis applies to a group of four chimeras rep-
resenting all combinations of the roll and C-helix sub-543 Young et al. 
domains of fCNG2 and rCNG5, so it does not assign the
subdomain interaction to a speciﬁc subdomain pair.
We cannot distinguish, for example, whether the ex-
tremely low efﬁcacy of X- R/ C reﬂects the absence of
a favorable interaction or the presence of an unfavor-
able interaction between the fCNG2 roll and rCNG5
C-helix subdomains. However, our result makes the key
point that among the four chimeras of this study, ener-
getic coupling through subdomain interaction is neces-
sary to account for the variation in efﬁcacy. This is sig-
niﬁcant: subdomain interaction (direct or indirect) can
determine efﬁcacy only if the relative orientation and
distance between subdomains are subject to a rigid con-
straint at some stage of the channel opening transition.
The interaction itself may exist only in particular BD se-
quences, but if the BDs in all four chimeras have struc-
tures that closely resemble the BD structure in intact
CNG channels (as is suggested by numerous lines of ev-
idence), then it is likely that the structural constraint
that is prerequisite for the subdomain interaction will
be a general feature of normal BD structure.
Nonadditivity of subdomain replacement effects is de-
monstrable on the basis of qualitative differences in
opening efﬁcacies among the four subdomain-pair chi-
meras, and is therefore essentially model-independent.
However, adopting a minimal model with a single open
and closed state enables estimation of the strength of
the subdomain interaction from thermodynamic link-
age analysis of  Gsat,cAMP. We have not validated the mini-
mal model with kinetic analysis of our chimeras, but
the use of more complex models would change only
the quantitative estimates and not our essential conclu-
sions. We stress that the interaction coupling energy
(  Gint,cAMP) calculated from linkage analysis represents
the energy of those particular subdomain interactions
that cause preferential stabilization of the open state,
and not simply the energy of all subdomain interactions.
Our calculated  Gint,cAMP of  11.5 kJ/mol is large
enough to represent multiple van der Waals contacts.
Interaction coupling energies of this magnitude have
not previously been reported either for interactions
between the two BD subdomains or between the BD
and non-BD regions. A previous point mutation study
(Scott and Tanaka, 1998) found coupling between resi-
dues F533, K596 and D604 within the BD of bCNG1,
and these residues were also found to inﬂuence the ac-
tion of Ni2  on the C-linker, but all the interaction cou-
pling energies were  3 kJ/mol, markedly smaller than
ours. This difference in magnitude is reasonable be-
cause our study examines the combined effects of all se-
quence differences between two BDs rather than the ef-
fects of single point mutations. Another interaction has
been identiﬁed, between the NH2- and COOH-termi-
nal regions (Gordon et al., 1997; Varnum and Zagotta,
1997), but it was found that the bCNG1 and rCNG2
COOH-terminal regions formed identical interactions
with the rCNG2 NH2-terminal region (presumably be-
cause the COOH-terminal residues involved in the in-
teraction are conserved between bCNG1 and rCNG2).
If indeed energetic coupling of the BD with the NH2-
terminal region is a determinant of efﬁcacy, the magni-
tude of its contribution remains unknown. Our study is
the ﬁrst to show that the total interaction coupling en-
ergy from BD subdomain interactions can be several-
fold larger than kT; indeed, the interaction energy is
comparable in magnitude to the entire   Gsat,cAMP be-
tween some chimeras, such as that between X-  and
X- . Therefore, subdomain interaction can be a major
determinant of the functional differences between
CNG channel subunits.
Simultaneous interaction of the two subdomains with
ligand is an intuitive premise of models for CNG chan-
nel activation. Our measurement of signiﬁcant subdo-
main interaction coupling energy places constraints on
the construction of such models. For instance, one sim-
ple model posits state-dependent subdomain interac-
tions with the purine ring in the cyclic nucleotide as a
mechanistic basis for switching the channel between
the open and closed state (Varnum et al., 1995). When
the channel is closed, the purine ring makes contacts
with the roll rather than the C-helix; during channel
opening, the purine rotates around the N-glycosidic
bond, breaking its contacts with the roll to form a
highly favorable interaction with the C-helix. (The cy-
clic phosphate and ribose are thought to make interac-
tions with the roll subdomain that are the same in the
open and closed channel.) This “rotamer” model in its
simplest form posits no other roll–C-helix interactions
save that taking place through the ligand. However, this
would predict that changes in the strength of the roll–
purine contact should be independent of changes in
the strength of the C-helix–purine contact, because the
purine does not contact the two subdomains simulta-
neously, and the connection between the purine and
the ribose is not rigid. Thus, nonadditivity could be ex-
plained if the rotamer model were modiﬁed to include
either (1) a direct state-dependent roll–C-helix interac-
tion at some other locus, or (2) a purine–roll interac-
tion in the open state (i.e., simultaneous interaction of
the C-helix and roll with different halves of the purine
ring during the open state).
Roll residues interacting with the purine ring likely
include the previously studied position 533 (Scott and
Tanaka, 1998), which is phenylalanine in fCNG2 and ty-
rosine in rCNG5. However, interaction coupling energy
 10 kJ/mol is generally too large to be derived from a
single pair of residues, except in the case of oppositely
charged side chains  4 Å apart (Schreiber and Fersht,
1995). We feel it is most likely that the large interaction
coupling energy found in our study indicates the pres-544 Efficient Coupling by a CNG Channel   Subunit Binding Domain
ence of novel determinants of activation that were not
previously identiﬁed; future work will aim at pinpoint-
ing such residues. A parallel avenue of study is the con-
tinued exploration of the functional properties of BDs
from other CNG channel subunits, whether of the con-
ventional ( ) or modulatory ( ) type. This will eventu-
ally allow compilation of a roster of BD residues that
can be used in different combinations to tune the efﬁ-
ciency of ligand-gating in CNG channels.
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